Pitcairn CO Danaher Corp Transaction History

Pitcairn CO

$1.67 Billion
Q3 2024

A detailed history of Pitcairn CO transactions in Danaher Corp stock. As of the latest transaction made, Pitcairn CO holds 17,056 shares of DHR stock, worth $3.98 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

17,056

Previous 18,375 7.18%

Holding current value

$3.98 Million

Previous $4.59 Million 3.29%

% of portfolio

0.28%

Previous 0.28%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$239.25 - $280.76 $315,570 - $370,322	-1,319 Reduced 7.18%	17,056 $4.74 Million
Q2 2024 Aug 13, 2024	SELL	$235.51 - $267.98 $93,732 - $106,656	-398 Reduced 2.12%	18,375 $4.59 Million
Q1 2024 May 13, 2024	BUY	$224.58 - $256.19 $564,369 - $643,805	2,513 Added 15.46%	18,773 $4.69 Million
Q4 2023 Feb 14, 2024	BUY	$185.1 - $233.13 $506,063 - $637,377	2,734 Added 20.21%	16,260 $3.76 Million
Q3 2023 Nov 13, 2023	BUY	$233.08 - $265.59 $495,994 - $565,175	2,128 Added 18.67%	13,526 $3.36 Million
Q2 2023 Aug 11, 2023	SELL	$224.99 - $256.14 $498,577 - $567,606	-2,216 Reduced 16.28%	11,398 $2.74 Million
Q1 2023 May 05, 2023	BUY	$239.75 - $277.0 $155,597 - $179,773	649 Added 5.01%	13,614 $3.43 Million
Q4 2022 Feb 13, 2023	SELL	$241.42 - $282.29 $13,760 - $16,090	-57 Reduced 0.44%	12,965 $3.44 Million
Q3 2022 Nov 10, 2022	BUY	$247.06 - $1507.4 $310,554 - $1.89 Million	1,257 Added 10.68%	13,022 $3.36 Million
Q2 2022 Aug 12, 2022	SELL	$237.11 - $299.66 $434,385 - $548,977	-1,832 Reduced 13.47%	11,765 $2.98 Million
Q1 2022 May 12, 2022	BUY	$257.27 - $315.76 $92,102 - $113,042	358 Added 2.7%	13,597 $3.99 Million
Q4 2021 Feb 14, 2022	BUY	$292.08 - $329.01 $97,554 - $109,889	334 Added 2.59%	13,239 $4.36 Million
Q3 2021 Nov 10, 2021	SELL	$272.21 - $332.43 $1.99 Million - $2.44 Million	-7,326 Reduced 36.21%	12,905 $3.93 Million
Q2 2021 Aug 11, 2021	SELL	$225.08 - $271.69 $1.5 Million - $1.81 Million	-6,673 Reduced 24.8%	20,231 $5.43 Million
Q1 2021 May 10, 2021	BUY	$212.38 - $245.9 $149,090 - $172,621	702 Added 2.68%	26,904 $6.06 Million
Q4 2020 Feb 05, 2021	SELL	$212.5 - $245.46 $25,075 - $28,964	-118 Reduced 0.45%	26,202 $5.82 Million
Q3 2020 Nov 03, 2020	SELL	$177.16 - $215.33 $212,946 - $258,826	-1,202 Reduced 4.37%	26,320 $5.67 Million
Q2 2020 Jul 28, 2020	BUY	$128.7 - $176.83 $101,286 - $139,165	787 Added 2.94%	27,522 $4.87 Million
Q1 2020 May 13, 2020	SELL	$121.39 - $169.05 $334,672 - $466,070	-2,757 Reduced 9.35%	26,735 $3.7 Million
Q4 2019 Feb 12, 2020	SELL	$133.47 - $153.48 $201,539 - $231,754	-1,510 Reduced 4.87%	29,492 $4.53 Million
Q3 2019 Nov 12, 2019	SELL	$135.4 - $146.47 $90,311 - $97,695	-667 Reduced 2.11%	31,002 $4.48 Million
Q2 2019 Aug 12, 2019	SELL	$124.88 - $143.73 $58,693 - $67,553	-470 Reduced 1.46%	31,669 $4.53 Million
Q1 2019 May 07, 2019	BUY	$97.62 - $132.29 $42,562 - $57,678	436 Added 1.38%	32,139 $4.24 Million
Q4 2018 Feb 12, 2019	SELL	$94.85 - $109.54 $80,907 - $93,437	-853 Reduced 2.62%	31,703 $3.27 Million
Q3 2018 Nov 02, 2018	SELL	$98.13 - $108.9 $137,382 - $152,460	-1,400 Reduced 4.12%	32,556 $3.54 Million
Q2 2018 Aug 02, 2018	SELL	$96.1 - $103.24 $159,237 - $171,068	-1,657 Reduced 4.65%	33,956 $3.35 Million
Q1 2018 May 11, 2018	SELL	$92.16 - $103.8 $429,281 - $483,500	-4,658 Reduced 11.57%	35,613 $3.49 Million
Q4 2017 Feb 13, 2018	SELL	$85.26 - $94.62 $193,625 - $214,882	-2,271 Reduced 5.34%	40,271 $3.74 Million
Q3 2017 Nov 03, 2017	BUY	$79.29 - $88.45 $3.37 Million - $3.76 Million	42,542	42,542 $3.65 Million

Others Institutions Holding DHR

# of Institutions

2,507

Shares Held

542M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $170B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pitcairn CO, based on Form 13F filings with the SEC.

News

Stay updated on Pitcairn CO with notifications on news.

Account